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SUMMARY
Ciliopathiesareabroadclassofhumandisorderswith
craniofacial dysmorphology as a common feature.
Among these is high arched palate, a condition that
affects speech andquality of life. Using the ciliopathic
Fuz mutant mouse, we find that high arched palate
does not, as commonly suggested, arise from mid-
face hypoplasia. Rather, increased neural crest ex-
pands the maxillary primordia. In Fuz mutants, this
phenotype stems from dysregulated Gli processing,
which in turn results in excessive craniofacial Fgf8
gene expression. Accordingly, genetic reduction of
Fgf8 ameliorates the maxillary phenotypes. Similar
phenotypes result from mutation of oral-facial-digital
syndrome 1 (Ofd1), suggesting that aberrant tran-
scription of Fgf8 is a common feature of ciliopathies.
High arched palate is also a prevalent feature of fibro-
blast growth factor (FGF) hyperactivation syndromes.
Thus, our findings elucidate the etiology for a com-
mon craniofacial anomaly and identify links between
two classes of human disease: FGF-hyperactivation
syndromes and ciliopathies.
INTRODUCTION
Craniofacial dysmorphology is a common component of the cili-
opathy disease spectrum, but while defective neural crest (NC)
cell migration has been implicated in Bardet-Biedl Syndrome
(BBS) (Tobin et al., 2008), little else is known about the underlying
developmental processes in ciliopathy-associated craniofacial
defects. Among the more consistent craniofacial phenotypes in
ciliopathies is the presence of a high arched palate (Beales
et al., 1999). In this condition, the palate is characterized by a
pronounced median groove, but the roof of the mouth remains
intact across the midline. This condition is often referred to as
a ‘‘pseudo-cleft.’’ Later in life, a high arched palate is also asso-
ciated with secondary dental anomalies, such as postnatal
gingival swelling and crowding of the molars. These defects
can impair speech and complicate intubation, a major concern
for craniofacial patients who frequently requiremultiple surgeries
during childhood. Thus, high arched palate has a significant
impact on patients’ quality of life.
The etiology of high arched palate remains obscure. One long-
held hypothesis proposes that the arch arises from a midface
hypoplasia causing insufficient maxillary growth and subsequent
compression of the upper dental arch (Hennekam et al., 2010;
Kreiborg and Cohen, 1992; Slaney et al., 1996). However, recent
morphometric analyses suggest that this may not be true (Martı´-
nez-Abadı´as et al., 2010). Although a chemically induced rat
model has existed for several decades, the embryological pro-
gression of the phenotype is unknown (Lorente et al., 1981). Sur-
prisingly, no genetic model of high arched palate has yet been
reported, so the underlying cellular and anatomical causes
remain unknown and developmental hypotheses are untested.
Clinical observations also complicate our picture of high
arched palate, as this defect is associated with a variety of seem-
ingly unrelated syndromes (Hayward et al., 2004; Hennekam
et al., 2010; Kreiborg and Cohen, 1992; Vadiati Saberi and Sha-
koorpour, 2011). For example, though rarely mentioned in the
literature, high arched palate is a central feature in many ciliopa-
thies, including BBS, oral-facial-digital syndromes (OFD types I
and IV), Joubert syndrome, and Sensenbrenner syndrome
(Beales et al., 1999; Hennekam et al., 2010; Moore et al., 2005;
Prattichizzo et al., 2008; Sensenbrenner et al., 1975; Somlo
et al., 1993). In fact, 88% of BBS patients present with high
arched palate, and many also display associated dental crowd-
ing and soft tissue swellings (Beales et al., 1999). High arched
palate is also consistently observed in an array of syndromes
characterized by dysregulation of fibroblast growth factor
(FGF) signaling or downstream components such as the Ras ki-
nase (Goodwin et al., 2012). Examples include Apert, Crouzon,
Muenke, and cardio-facio-cutaneous syndromes (Agochukwu
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et al., 2012; Berkowitz, 1971; Hennekam et al., 2010; Kreiborg
and Cohen, 1992; Letra et al., 2007; Rynearson, 2000; Vadiati
Saberi and Shakoorpour, 2011). This finding is curious, because
while FGF signals have been implicated in controlling cilium
length (Hong and Dawid, 2009; Neugebauer et al., 2009), there
has been no evidence to date suggesting a link between FGF
dysregulation syndromes and the ciliopathies.
To characterize ciliopathic craniofacial defects, we examined
mice with a mutation in the gene encoding Fuzzy (Fuz), which
has recently emerged as a key regulator of ciliogenesis (Gray
et al., 2009; Park et al., 2006). Initially described as a Drosophila
planar cell polarity effector gene (Collier and Gubb, 1997),
studies in both Xenopus and mice identified Fuz as a central
regulator of vertebrate ciliogenesis (Brooks and Wallingford,
2012; Gray et al., 2009; Park et al., 2006). Consistent with the
key role of cilia in Hedgehog (Hh) signaling, disruption of Fuz
affects Hedgehog-dependent patterning events in both frogs
and mice (Gray et al., 2009; Park et al., 2006), and in mice, loss
of Fuz has been shown directly to disrupt the processing of
Gli3 (Heydeck et al., 2009). Recently, live imaging analyses re-
vealed that Fuz is essential for normal trafficking of the retro-
grade intraflagellar transport (IFT) machinery in vertebrate cilia;
when Fuz is depleted, localization of IFT-A proteins, such as
IFT43, is disrupted (Brooks and Wallingford, 2012). As a conse-
quence, IFT trains become stalled, leading to shortened cilia and
impaired signal transduction. Finally, Fuz is of particular interest
because it is mutated in human patients with birth defects (Seo
et al., 2011) and because Fuz mutant mice display a variety of
craniofacial phenotypes (Zhang et al., 2011).
Here, we present the Fuz mutant mouse as a useful genetic
model for the study of high arched palate. Although current
Figure 1. Fuz Mutant Mice Are a Model for
High Arched Palate
(A and B) Ventral views of E17.5 palates. Mutants
exhibit a narrow palate (arrowheads) and dis-
rupted rugal organization compared to littermates.
(C and D) Sirius red/alcian blue staining of E17.5
coronal sections. Bilateral palatine bones are
formed in both control and mutant, abutting at the
midline (black). Mutant palatine bones (Pb) are
mediolaterally shortened with an increase in the
ventral extension. Note enlarged palatal mesen-
chyme (P). Molars (M) appear normal.
(C0 and D0) Schematics depicting skewed palatal
anatomy.
(E–J) Hemotoxylin and eosin staining of coronal
sections at indicated stages.
(E0–J0) Schematics of sections identifying palatal
mesenchyme (gray, P), molars (blue and purple,
M), and palatal bone condensations (red, Pb). In
(H) through (J0 ), mutant palatal condensations are
medially constrained and do not extend into the
oral cavity. Palatine bone can be observed in both
mutants and controls by E16.5.
See also Figure S1.
hypotheses suggest that high arched pal-
ate arises from constriction of the upper
jaw (Hennekam et al., 2010), our data
demonstrate that the primary cause of cil-
iopathic high arched palate is instead excessive NC producing an
enlarged first branchial arch (BA1) andmaxillary hyperplasia early
in embryogenesis. We have also discovered a surprising mecha-
nistic basis for this phenotype, as we observed a dramatic
increase in FGF signaling due to increased cranial Fgf8 gene
expression. Genetic reduction of Fgf8 rescues the maxillary
defects in Fuzmutant mice. Finally, we observed a similar maxil-
lary expansion and upregulation of Fgf8 expression in another cili-
opathymousemodel,OFD-1 (Ferranteet al., 2006). Thus,wehave
identified dysregulation of FGF function as the cause of facial de-
fects in ciliopathic mutant mice, demonstrating etiological com-
monalities between two broad categories of human congenital
anomalies: the ciliopathies and the FGF-related syndromes.
RESULTS
Fuz Mutant Mice Are a Model of High Arched Palate
Fuz mutant mice appear to have a cleft secondary palate (Fig-
ures 1A and 1B); however, frontal sections revealed that the
palatal shelves were, in fact, not clefted (Figures 1C–1D0).
Instead, in all mutants analyzed, the palatine bones displayed
the classic inverted-V shape typical of a high arched palate
(Figures 1D–1D0). Palatal narrowing and palatine bone defects
were observed throughout the anterior-posterior extent of the
secondary palate in mutants (Figure S1 available online). We
also observed expanded mesenchyme within the oral cavity
in Fuzmutant mice (Figure 1D, ‘‘P’’ in light blue area; Figure 1D0,
gray area). Thus, the maxillary phenotypes of Fuz mutant mice
bear a striking similarity to the high arched palate reported for
human ciliopathy patients (Beales et al., 1999; Hennekam et al.,
2010; Tagliani et al., 2010).
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The embryological events leading to high arched palate have
not been previously described, so we compared maxillary devel-
opment in a staged series of wild-type and Fuz/ littermates. In
controls, the palatal shelves developed bilaterally, growing and
extending ventrally into the oral cavity at E13.5 (Figures 1E
and 1E0). The palatal primordia were evident at the appropriate
stage in Fuz mutants but were displaced medially compared to
littermates and did not extend ventrally (Figures 1H and 1H0, out-
lined in gray). At E14.5, palatal condensations in controls
remained bilateral and were fully extended, flanking the tongue
(Figures 1F-1F0), with the palate fusing by E16.5 (Figures 1G
and 1G0). In mutants, however, the palatal condensations did
not extend and instead appeared as one contiguous domain
(Figures 1I–1J0). This medial shift of the palatal shelves was
also evident from Patched1 (Ptc1) expression, which spans
the midline (Figure S1A and S1B). Likewise, ossification of pala-
tine bones was apparent at E17.5 in controls, and in Fuzmutants
the palatine bones were displacedmedially (Figures 1D and 1D0).
Furthermore, analysis by microcomputed tomography (mCT)
revealed that the majority of midfacial bones are present and
ossifying. Though small and constrained, the mutant palatine
bones are roughly normal in shape (Figures S1M–S1M00). These
data raised the intriguing possibility that a recognizable palate
can form despite an initial failure of shelf outgrowth (Figures 1H
and 1H0).
Fuz Mutant Mice Displayed Enlarged Maxillary
Processes
When examined at earlier stages, we found that a largermaxillary
process was evident in Fuzmutants as early as E9.0 (Figures 2A
and 2B); by e9.5 the maxillary domain is substantially larger
(compare Figures 2C and 2E to Figures 2D and 2F). Cell numbers
were significantly increased in themaxilla, but there was no coin-
cident increase in mitotic cells or change in apoptosis (Figures
2G and 2H; data not shown). Overall, this developmental pro-
gression is strikingly divergent from that underlying traditional
cleft palates (Chai and Maxson, 2006), suggesting that the high
arched palate, though commonly referred to as a ‘‘pseudo-
cleft,’’ is unrelated to cleft palate and arises by a distinct devel-
opmental mechanism.
Disruption of Fuz Leads to Excessive NC
We next sought to better understand the developmental origin
of this defect. Because the maxillary process normally arises
from NC cells emanating from the posterior mesencephalon,
we lineage-traced the NC using a Wnt1-cre driver to follow
cell migration into BA1 (Figures 2A and 2B0 blue/lacZ; Figures
2I–2L green/green fluorescent protein [GFP]) (Danielian et al.,
1998; Muzumdar et al., 2007; Soriano, 1999). In Fuz mutants,
we observed an early expansion of cranial NC cells (Figures
2A and 2B). In Figure 2B, the rostral extent of this expansion
is marked by an asterisk. We also observed a general expansion
of midhindbrain streams (Figures 2A–2B0; note brackets in Fig-
ures 2A and 2B). Most strikingly, dorsal views of these embryos
revealed a substantial increase of labeled cells in BA1 and
the second branchial arch (BA2) (arrowheads, Figures 2A0
and 2B0). To confirm the increase in the NC, we isolated E9.25
cranial tissues from a reporter line expressing membrane GFP
(mT/mG) when crossed to the Wnt1-cre driver (schematic in
Figure 2O) (Danielian et al., 1998; Muzumdar et al., 2007). Using
flow cytometry, we analyzed Wnt1-cre induced GFP-positive
cells and found a significant increase in the proportion of NC
cells (summarized in Figure 2P; representative plot per geno-
type in Figure 2O). These experiments suggest that the
observed maxillary hyperplasia may stem from an excess of
NC cells.
Loss of Fuz Leads to Disorganized NC Migration
In addition to the significant increase in NC cell numbers, the
migration of the NC was disrupted in Fuz mutant mice. For
example, we frequently observed a large proportion of rostral
crest cells collecting ectopically in the optic cup regions (Fig-
ure 2B, arrowhead). To examine this at a cellular level, we utilized
membrane-bound GFP in Wnt1-cre; R26mT/mG embryos. Strik-
ingly, three-dimensional confocal imaging revealed that the
depth of the migratory streams was far greater in Fuz mutants
(79 ± 16 mmdeep inmutants versus 41 ± 20 mmdeep in wild-type
embryos; Figures 2K and 2L). This was surprising, as mesence-
phalic NC cells should remain adjacent to the epidermal ecto-
derm, avoiding the underlying mesenchyme (Noden, 1975).
Furthermore, we noted cells rostral to the trigeminal ganglion
in a region that should ordinarily be clear of NC cells (compare
Figure 2I0 to Figure 2J0).
We had previously shown that morpholino oligonucleotides
(MOs) were an effective means to block Fuz function in Xenopus
(Park et al., 2006). When we examined expression of Twist, a
migratory NC marker, following Fuz knockdown, we observed
aberrant migration of the anterior cranial crest (Figures 2M and
2N, arrowheads), consistent with the observed craniofacial
defects (Park et al., 2006). In many cases, we noted increased
and ectopic migration of the anterior NC into the eye field (Fig-
ure 2N, black arrowhead and inset). Together, these data sug-
gest that Fuz plays an evolutionarily conserved role in controlling
NC cell contributions to BA1.
Disruption of Cranial Hedgehog Signaling at Early
Stages in Fuz Mutant Mice
We next sought to understand the molecular basis of the maxil-
lary hyperplasia in Fuz mutant mice. Fuz controls ciliogenesis,
and cilia are central to proteolytic cleavage of Gli effector pro-
teins that transduce Hedgehog signals (Goetz and Anderson,
2010; Liu et al., 2005; Singla and Reiter, 2006). Indeed, loss of
Fuz leads to defective Hedgehog signaling in the spinal cord
and limb (Gray et al., 2009; Heydeck et al., 2009; Park et al.,
2006), and Heydeck et al. showed that, during patterning of
the limb, Fuz mutation leads to aberrant proteolytic processing
of Gli3 (Heydeck et al., 2009).
However, changes in palatal Hh signaling could not account
for the observed craniofacial phenotypes, as the Hh target
gene Ptc1 continues to be expressed in Fuz mutant palatal
primordia at E14.5 (Figures S1A–S1B0), and unlike the Fuzmuta-
tion, loss or gain of Hh activation in the palate leads to a true cleft
rather than an arched palate (Cobourne et al., 2009; Gritli-Linde
et al., 2007; Hu and Helms, 1999; Lan and Jiang, 2009; Mo et al.,
1997; Rice et al., 2004). Furthermore, Gli3 mutation also leads
to sporadic cleft palate due to obstruction by the tongue (Huang
et al., 2008). These data suggest that, if a Gli processing defect
is involved, it must occur prior to palate formation.
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Figure 2. Increase in NC in Maxillary Compartment
Wnt1-cre-driven LacZ (blue) or GFP (green) marks NC contributions.
(A and B) Lateral views of E9.25 embryos. BA1 and BA2NC streams are wider compared to controls (B compared to A, yellow bracket). Increased NC disrupts the
optic cup (OC) in Fuzmutants compared to controls (B compared to A, arrowhead). BA2NC stream is also increased in size and has failed tomigrate as far as BA2
control NC. Mx, maxillary compartment of BA1. OV, optic vesicle.
(A0 and B0) Dorsal views. Maxillary BA1 is enlarged compared to controls (B compared to A, top arrowhead). BA2 has failed to migrate sufficiently compared to
controls (bottom arrowhead).
(C and D) PH3 staining (green) and DAPI (blue) of E9.0, maxillary compartment. Mutant maxilla is enlarged (white dotted line).
(E and F) Coronal sections of E10.5Wnt1-cre; R26RmT/mG; Fuz+/+, orWnt1-cre; R26RmT/mG;Fuz/ maxillae.Wnt1-cre-driven membrane-GFP (green) marks NC
contributions. Epithelialmembrane-Tomato (red) highlightsall other tissuederivatives.Mutantmaxillae are larger compared to controls. Enlargedmaxillae comprise
NC-derived mesenchyme.
(G) Quantification of DAPI-positive cells from representative sections of E9.5 and 10.5 embryos. Note increase in cell number in mutant (red) maxilla compared to
wild-type (blue) (p < 0.004). Error bars indicate SD.
(H) Quantification of E9.5 maxillary PH3-positive cells compared to total cell number. A significant decrease in the percentage of PH3-positive cells is observed in
mutant maxillae (red) compared to controls (blue) (p < 0.01). Error bars indicate SD.
(I and J) Single confocal z-sections of Wnt1-cre; R26RmT/mG;Fuz+/+ or Wnt1-cre; R26RmT/mG;Fuz/ E9.5 embryos. Wnt1-cre-driven membrane-GFP (green)
marks NC contributions.
(I0–J0 ) Magnified maximum projections of (I) and (J), indicated by a white dotted box. In controls, chains of Wnt1-cre-driven membrane-GFP-positive NC are
observed (yellow arrowheads), with few isolated cells between brain and maxillary compartment (white arrowheads). Isolated NC cells are observed in mutant
embryos, indicated by a white arrowhead in (J0), and NC chains are disorganized.
(legend continued on next page)
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As it happens, Gli3 plays a crucial role in patterning the tissues
that give rise to NC destined for BA1 (Blaess et al., 2006). There-
fore, we assessed Hh signaling in the cranial regions of e9.0
embryos. We found a dramatic increase of full-length Gli3 in
our mutants and a concurrent decrease in the short repressor
form of Gli3 (Figure 3A). We also observed a reduction of Hh
target gene expression in cranial tissues (Figure 3B), which
may contribute to the observed NC defect.
Expanded FGF Expression in FuzMutants
We then considered molecular changes downstream of the early
Gli processing defects in Fuz/ mice. One possibility was that
(K and L) Z-projections of (I0 ) and (J0). The thickness of NC streams anterior to the prospective trigeminal ganglion is increased in mutants (WT = 41 ± 20 mm thick;
mutant = 79 ± 16 mm deep). The immediately underlying membrane-Tomato-positive mesenchymal cells are shown in red, at the bottom of the image. The
overlying epithelium is not included. Scale bar, 100 mm. This doubling in thickness is consistent with increased NC invasion into BA1.
(M and N) Twist in situ hybridization of stage 22 embryos injected unilaterally with FuzMO. In controls, Twist is expressed in three streams, where the anterior NC
stream surrounds the optic placode, indicated in (M) by open arrowhead and inset (bracket). Ectopic Twist expression is observed in the optic placode in Fuz
morphants, indicated in (N) by arrowhead and inset (bracket).
(O) Representative epifluorescence image of an E9Wnt1-cre; R26mT/mG embryo. Lineage-traced NC cells are labeled GFP (green), and nonrecombined cells are
Tomato positive (red). Dashed line illustrates where embryos were bisected caudal to BA1. Wnt1-cre; R26RmT/mG; Fuz+/+, or Wnt1-cre; R26RmT/mG;Fuz/
embryo heads were dissociated and GFP positive, Tomato, or double-labeled cells were analyzed by flow cytometry. Representative flow cytometry plots from
single E9 Wnt1-cre; R26mT/mG; Fuz+/+, or Wnt1-cre; R26RmT/mG;Fuz/ dissociated heads. mG, Wnt1-cre-driven membrane-GFP; mT, membrane-Tomato.
(P) The percentage of Wnt1-Cre-driven GFP-positive cells was significantly increased in mutants (79% ± 2%) compared to controls (68% ± 1%) (p = 0.0103).
Whiskers represent maximum/minimum data values with median and quartiles represented in the box.
Figure 3. Gli3 Processing and Hh and FGF
Signaling Are Altered in Fuz Mutants
(A) Western blot analysis of activator and
repressor forms of Gli3 (Gli3-L and Gli3-S,
respectively) in E9.0 embryos. Increased Gli3-L
and reduced Gli3-S was detected in Fuz/
embryos in (A), lanes 3–5, compared to controls
in (A), lanes 1 and 2. Alpha-tubulin was analyzed
as a loading control.
(B) qPCR of Hh target genes Patched 1 (Ptc1) and
Gli1 from E9.0 Fuz+/+ and Fuz/ heads. Relative
mRNA levels are normalized to b-actin. Ptc1 and
Gli1 are decreased in mutants (red) compared to
controls (blue). Whiskers represent maximum/
minimum data values with median and quartiles
represented in the box.
(C and D) Lateral views of Fgf8 expression in E9.0
embryos. Fgf8 is expressed in the midhindbrain
boundary (MHB), frontonasal prominence (FNP),
and the BA1 epithelium. In mutants, Fgf8 expres-
sion domains are expanded, indicated by bracket
and arrowheads.
(C0 and D0) Magnified view of BA1 in control and
mutant embryos. Dotted line indicates extent of
maxillary compartment. Note enlarged maxillary
prominence.
(E and F) Frontal view of Fgf8 expression in E10.5
embryos. Note mediolateral expansion of maxil-
lary Fgf8 expression in the mutant, indicated by
black arrowhead.
(G and H) Lateral views of Erm1mRNA expression
in E9.5 embryos. Erm1 is expressed in the MHB,
FNP, and BA1. In mutants, expression of Erm1 is
expanded ventrally from the MHB (yellow asterisk)
and in BA1 (yellow bracket).
(G0 and H0) Magnified view of BA1. Erm1 expres-
sion is increased in mutant maxillae (yellow
arrowheads).
(I and J) Lateral views of Pea3 expression in E9.5
embryos. Pea3 is expressed in theMHB, FNP, and
BA1. In mutants, expression of Pea3 is expanded
in BA1 (yellow bracket).
(I0 and J0) Magnified view of BA1 in control and
mutant embryos. Pea3 expression is increased in
mutant maxillae (yellow arrowhead).
See also Figure S2.
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loss of Fuz leads to upregulation ofWnt target genes (e.g., Zhang
et al., 2011); however, we found no changes in levels of activated
b-catenin at early stages (e9.0) in Fuz/ heads (data not shown).
Next, as mentioned, high arched palate is common in FGF
hyperactivation syndromes (Hajihosseini et al., 2001; Itoh and
Ornitz, 2011; Wilkie et al., 1995). While there is no link between
cilia and FGF signal transduction per se, loss of Gli3 can lead
to increased Fgf8 gene transcription, most obviously in the telen-
cephalon (Aoto et al., 2002; Blaess et al., 2006; Cordero et al.,
2004; Kuschel et al., 2003; Okada et al., 2008; Rash and Grove,
2007; Theil et al., 1999; Ueta et al., 2008). Indeed, a recent report
suggests that loss of cilia-dependent signaling can similarly
result in Fgf8 expansion during development of the corpus
callosum (Benadiba et al., 2012).
Therefore, we examined Fgf8 levels in Fuzmutants. Strikingly,
at E9.5, Fgf8 expression was significantly expanded in Fuz
mutants (Figures 3D and 3F), though there was minimal differ-
ence in mRNA levels prior to e9.0 (Figure S2). Fgf8 is normally
expressed in the midhindbrain boundary, the frontonasal
process, and at low levels within the lateral epithelium of the
maxillo-mandibular cleft (Figures 3C and 3C0). In Fuz mutants,
Fgf8 expression was expanded in all of these domains, with an
anterior expansion from the midhindbrain domain (Figure 3D,
bracket) and a mediolateral expansion within the mandibular
and maxillary prominences (Figures 3D and 3D0). This expansion
was maintained in mutant maxilla at E10.5 (Figure 3F). In addi-
tion, we found that Fuz knockdown in Xenopus also resulted in
broader Fgf8 gene expression, most strikingly in the domain
abutting the migratory NC and in the frontal midline (Figure S3).
Key transcriptional targets of FGF signaling, Erm1 and
Pea3 (Firnberg and Neubu¨ser, 2002; Raible and Brand, 2001;
Roehl and Nu¨sslein-Volhard, 2001), were strongly upregulated
in Fuz mutants (Figures 3I–3J0) including a clear rostral expan-
sion of both messenger RNAs (mRNAs) surrounding the
mesencephalon (Figures 3G–3J, asterisk). Furthermore, both
genes were robustly expressed throughout the expanded
maxillary primordia, in contrast to the wild-type littermates
(Figures 5H0 and 5J0, arrowhead). Together, these data iden-
tify a surprising role for Fuz in the regulation of Fgf8 gene
expression, and suggest that an aberrant increase in FGF
signaling underlies the craniofacial anomalies in Fuz mutant
mice.
Fgf8 Heterozygosity Rescues Maxillary Hyperplasia and
Palate Defects in Fuz Mutant Mice
Our analysis of Fuz mutants suggested that excessive FGF
signals drive the maxillary hyperplasia that underlies the
observed palate defects. To test this model directly, we asked
if decreasing the Fgf8 gene dose might ameliorate the craniofa-
cial defects in Fuz mutants. Using a null allele of Fgf8, in which
the coding region is replaced with the lacZ gene (Ilagan et al.,
2006), we halved the dose of Fgf8 in Fuz/ mice. We observed
substantial rescue of maxillary hyperplasia in Fuz/; Fgf8lacZ/+
compound mutants (compare Fuz mutants in Figures 4B
and 4B0 to rescued embryos in Figures 4C and 4C0). Heterozy-
gosity of Fgf8 also rescued the brain overgrowth and ocular
phenotypes observed in Fuz mutants (compare Figure 4E to
Figure 4F). Most strikingly, loss of one allele of Fgf8 restored
the e16.5 Fuz/ palate to a normal width (Figures 4H–4K; Fig-
ure S3), confirming that the early maxillary phenotype is due in
large part to an increase in FGF.
Because the Fgf8 and NC phenotypes we observed seemed
localized to the cranial structures, we hypothesized that pheno-
typic rescue after decreasing Fgf8 dose should be specific to the
head. Indeed, we found that Fgf8 heterozygosity had little effect
on digit development phenotypes in Fuzmutantmice (Figure S3).
Together, these data suggest that the proximate cause for
craniofacial defects in Fuz mutant mice is expanded Fgf8
expression, while the polydactyly is independent of Fgf8, result-
ing directly from aberrant cilia-mediated Gli3 regulation (Hey-
deck et al., 2009).
Conditional Disruption of Fuz in the NC Does Not Result
in High Arched Palate
Our data so far lead us to propose a model in which early dys-
regulation of cranial Gli processing in Fuz mutant mice leads to
excessive expression of Fgf8, which in turn causes an excess
of NC. We further propose that it is this early excess of NC,
rather than attendant crest migration defects, that results in
maxillary hyperplasia and high arched palate. To test this
model, we used the NC-specific Wnt1-cre driver to condition-
ally delete the Fuz gene. Notably, specific deletion of Fuz in
NC cells did not elicit early hyperplasia of the maxillary process
or high arched palate (Figure 5; data not shown). Instead, these
animals had a true cleft, indicating that, in the NC, Fuz is
required only much later for palatal shelf elevation or depres-
sion of the tongue. These data suggest that the early maxillary
phenotypes in Fuz mutant mice result from Fuz requirements in
the neural tissue prior to NC induction (see also the model,
Figure 7).
Maxillary Hyperplasia and FGF8 Upregulation in OFD-1
Mice
We next asked if Fgf8misregulation might be a general principle
in ciliopathies. We examined the mouse model of OFD syn-
drome, Ofd-1 (Ferrante et al., 2006). OFD patients frequently
present with high arched palate (Figure 6F) (Hennekam et al.,
2010; Prattichizzo et al., 2008; Tagliani et al., 2010), and OFD-1
is essential for ciliogenesis and centriole morphology (Ferrante
et al., 2006; Singla et al., 2010). Importantly, Ofd-1 mutant
animals were strikingly similar to the Fuz/ animals, with an
enormously enlarged maxillary process and a clear expansion
of cranial Fgf8 expression (Figures 6A–6D).
Broad Similarity between Fuz Mutant Mice and FGF
Hyperactivation Syndromes
Finally, the similarity of palatal phenotypes between OFD
patients and patients with FGF hyperactivation syndromes
such as Apert (Figures 6E–6G) suggest that ciliopathic cranial
phenotypes stem from excessive FGF signaling. If this were
the case, we hypothesized that Fuz/ mice might also display
craniosynostosis, another common feature of FGF hyperactiva-
tion syndromes. Therefore, we examined skull ossification
using Alizarin red staining and found complete synostosis of
the coronal sutures in Fuz mutant mice, akin to that seen in
Apert syndrome (Figures 6I–6I0, arrowhead). Mutants also
displayed other hallmarks of FGF syndromes, including fusion
of the cervical vertebra and upper airway anomalies (data not
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shown) (Anderson et al., 1997; Kreiborg et al., 1992; Moore et al.,
1995). Thus, our data suggest widespread commonalities
between ciliopathic craniofacial defects and FGF hyperactiva-
tion syndromes.
Figure 4. Fgf8Reduction RescuesMaxillary
Hyperplasia and Palatal Width in Compound
Mutants
(A–C) Lateral views of BA1. Maxillary size is
expanded in Fuz/ mutants in (B) compared to
Fgf8LacZ/+ in (A). Maxillary expansion is rescued in
Fuz/; Fgf8LacZ/+ embryos in (C). Fgf8 expression
is also rescued in compound mutants as b-gal
staining reveals similar BA1 epithelial expression
in compound mutants and Fgf8 heterozygotes.
(A0–C0) Maxillary size is schematized for each
genotype.
(D–F) Lateral view, E12.5. Maxillary size is
expanded in mutants in (E) compared to Fgf8LacZ/+
in (D). Maxillary expansion is rescued in Fuz/;
Fgf8LacZ/+ embryos in (F). Normal Fgf8 expression
(b-gal/blue) is also restored in compoundmutants.
Brain overgrowth and eye defects are rescued in
compound mutants (arrowheads).
(G–I) Trichrome staining of coronal sections of
E16.5 embryos. Palatal width and bone angle are
decreased in mutant embryos in (H) compared to
controls in (G). Palatal width in Fuz/; Fgf8LacZ/+ in
(I) appears normal compared to controls in (H).
Angle of palatine bone is partially rescued when
compared to controls, as shown in (I) compared to
(G) and (H).
(J) Schematic of palatal anatomy.
(K) Quantification of palatal width in E16.5
Fuz+/+; Fgf8LacZ/+(blue), Fuz/; Fgf8+/+ (green),
and Fuz/; Fgf8LacZ/+(red) embryos. Palatal width
is significantly decreased in Fuz/; Fgf8+/+
compared to controls, while Fgf8 heterozygosity
rescues palatal width in Fuz mutants (p < 0.0005,
one-way analysis of variance). Whiskers represent
maximum/minimum data values with median and
quartiles represented in the box.
See also Figure S3.
DISCUSSION
Recent evidence reveals significant roles
for cilia in human development and dis-
ease. First, mutations in genes known to
promote cilia biogenesis and IFT have
been implicated in a number of human
syndromes (Ferkol and Leigh, 2012). Sec-
ond, analysis of animal models suggests
that a variety of developmental disorders,
including craniofacial dysmorphology,
result from defects in ciliary function
(Huber and Cormier-Daire, 2012). Finally,
advances in clinical genomics have
improved annotation of disease alleles,
subsequently identifying numerous, un-
classified syndromes as ciliopathies
(Brugmann et al., 2010). The challenge
now is understanding how these seem-
ingly heterogeneous disorders arise (Novarino et al., 2011), and
our data suggest that commonalities in phenotype are likely to
reflect shared signaling events, which converge into shared phe-
notypes. The results reveal an association between ciliopathies
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and FGF syndromes, in turn providing insights into the diversity
of phenotypes seen in craniofacial anomalies.
We present the Fuz mutant as a genetic model of ciliopathic
high arched palate and provide experimental evidence of the
causes of this defect (Figure 7). Some aspects of skeletal devel-
opment in Fuz mutants have been previously described; how-
ever, those reports focus on mandibular outgrowth (Zhang
et al., 2011). We propose that the high arched palate arises
due to perturbation of facial development in the Fuz mutant
well before the stages examined previously and that the reported
effects on Hh and Wnt signaling are secondary to an earlier
developmental defect (Zhang et al., 2011).
Our data suggest that early expansion in Fgf gene expression
drives maxillary phenotypes in the Fuz mutant model (Figure 7),
but how does loss of a ciliopathy gene lead to an expansion of
FGF signaling? Inwild-type embryos,Gli3 repressor is expressed
in the midbrain, where it acts as a transcriptional repressor, and
indeed, Gli3R normally suppresses Fgf8 expression in neural
tissues, as loss of Gli3 leads to an increase in Fgf8 (Aoto et al.,
2002). Gli3 processing from Gli3-A (activator) to Gli3-R
(repressor) is thought to occur at the distal tip of the cilium (Fig-
ure 7A) (Endoh-Yamagami et al., 2009; Lai et al., 2011; Tukachin-
sky et al., 2010; Wen et al., 2010). This distal tip of
the ciliary axoneme is specifically lost in the absence of Fuz
(Brooks and Wallingford, 2012) and likely leads to attenuated
Gli3 processing (Figure 3). Subsequently, loss of Gli3R reduces
transcriptional inhibition, permitting expansion of hindbrain fates,
and Fgf8 expression.
Previous studies in chicken embryos have implicated brain-
specific Fgf8 in the control of NC numbers (Creuzet et al.,
2004). How does this occur? DiI labeling has shown that, in
mouse, anterior NC destined for BA1 arises from the posterior
mesencephalon and rhombomere 1 (Osumi-Yamashita et al.,
1994). Loss of Hh activity leads to dorsalization or expansion
of these structures (Fedtsova and Turner, 2001), concurrently
increasing Fgf8 expression and the NC domain. As a conse-
quence, increased numbers of NC cells migrate toward BA1,
overfilling it and forming enlarged maxillae (Figures 2 and 3).
Subsequently, Fgf8 is also upregulated in the BA1 epithelium,
as well as in the frontonasal prominence (Figure 3). Following
NC migration, the palatal condensation (Figure 7, red) arises
medially, adjacent to Fgf8 expression domains; in mutants, the
grossly enlarged maxillary region causes a medial shift in palatal
condensations (Figure 7).
These findings are significant for exposing an etiological link
between the ciliopathies and FGF hyperactivation disorders.
Furthermore, our data suggest that the long-held midface
hypoplasia model for high arched palate should be revisited
(Hayward et al., 2004; Hennekam et al., 2010). One source of
confusion may be the disparity between observations in human
patients versus phenotypes associated with mouse models. For
example, Snyder-Warwick and colleagues examine palatal
development in mice carrying a Crouzonmutation (FGFR2C342Y),
which causes increased FGF signaling associated with craniosy-
nostosis (Snyder-Warwick et al., 2010). In these mice, heterozy-
gotes, which should mirror the human genotype, have normal
palates. Furthermore, homozygotes have a true cleft, mimicking
a loss of FGFR2b (Hosokawa et al., 2009; Rice et al., 2004). This
clearly does not model the oral aspects of the human syndrome,
as it was noted nearly 40 years ago that true clefts in Crouzon
patients were likely to be misdiagnoses (Peterson and Pruzan-
sky, 1974).
Importantly, the relationship between ciliopathy and FGF
hyperactivation syndromes is not limited to the palate, as Fuz
mutant mice also display other manifestations of the FGFR-
associated syndromes, such as craniosynostoses, fusions of
the cervical vertebrae, and tracheal cartilaginous sleeve (Fig-
ure 6; data not shown). Finally, we note that this relationship is
not restricted to animal models, as high arched palate and
synostoses also co-occur in the human ciliopathy Sensenbren-
ner syndrome (Levin et al., 1977; Sensenbrenner et al., 1975).
Notably, the cilia defects in Sensenbrenner syndrome are
caused by mutations in proteins of the retrograde IFT particle,
including IFT43 (Arts et al., 2011), and we recently showed that
ciliogenesis defects following disruption of Fuz stem from a
failure of IFT43 trafficking (Brooks and Wallingford, 2012).
Thus, in summary, our studies of a high arched palate model
have revealed that excessive FGF transcription and increased
Figure 5. Maxillary Hyperplasia Is Not Due to Fuz Function in the NC
(A and B) Lateral views of E17.5 Wnt1-cre; Fuzfl/+ and Wnt1-cre; Fuzfl/
embryos. The control embryo in (A) is an albino and lacks pigment in the eye.
Arrowheads indicate rostral midline.
(A0 and B0) Frontal views of E17.5 Wnt1-cre; Fuzfl/+ and Wnt1-cre; Fuzfl/
embryos. A cleft lip is observed in conditional null embryos [(B0) compared to
(A0), indicated by arrowheads].
(A00 and B00) Hemotoxylin and eosin (H&E) staining of coronal sections of E17.5
Wnt1-cre; Fuzfl/+ and Wnt1-cre; Fuzfl/ embryos. Sections show the anterior
secondary palate (P), tongue (T), and molars (M). Palatal shelves are elevated
and fused across the midline in control embryos; however, a failure in shelf
elevation is observed in Wnt1-cre; Fuzfl/ embryos [(B00) compared to (A00),
indicated by P]. The tongue also appears smaller and irregularly shaped in
mutants [(B00) compared to (A00) indicated by T].
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NCmay be key factors in the poorly understood etiology of cilio-
pathic craniofacial defects. Furthermore, our report demon-
strates that the pathological events underlying this phenotype
are surprisingly different from those leading to a traditional cleft
palate, raising the possibility that clinical diagnoses and man-
agement of high arched palate should also be reconsidered in
this developmental and molecular context.
EXPERIMENTAL PROCEDURES
Mouse Lines
The followingmouse lines were used: Fuzmutants: Fuzgt(neo) (Gray et al., 2009);
conditional Fuz mutants: Fuzfl/fl, which were generated according to standard
methods and will be described elsewhere; conditional Ofd-1 mutants:
Ofd1tm2.1Bfra (Ferrante et al., 2006); Fgf8 mutants: Fgf8lacZ (Ilagan et al.,
2006); Wnt1-cre driver: Tg(Wnt1-cre)11Rth (Danielian et al., 1998); and
reporter lines: R26RmT/mG: GT(Rosa)26Sortm4(ACTB-tdTomato-EGFP)Luo (Muzum-
dar et al., 2007) and R26RlacZ:Gt(ROSA)26Sortm1Sor (Soriano, 1999). Genotyp-
ing was performed as described in the original publications cited earlier. In all
phenotypes depicted, at least four animals per genotype were examined. All
animal work was performed in accordance with UK Home Office Regulations.
Western Blotting
Tissues rostral to and including BA1 were dissected from E9.0 embryos. Pro-
tein preparations and western blotting were carried out according to estab-
lished protocols. Primary antibodies used were anti-Gli3 (clone H-280,
1:1,000, Santa Cruz Biotechnology no. sc-20688) and anti-alpha tubulin (clone
DM1a, 1:5,000, Sigma T6199). Chemiluminescent signal was visualized using
a BioRad ChemiDoc.
Real-Time PCR
Tissues rostral to and including BA1 were dissected from E9.0 embryos.
Reverse transcription and cDNA synthesis were carried out according to
standard protocols. Real-time PCR (RT-PCR) reactions were performed on a
Rotorgene Q 2-series using the following gene-specific primer pairs.
b-actin (F: CTAAGGCCAACCGTGAAAG, R: ACCAGAGGCATACAGG
GACA)
Gli1 (F: CAGGGAAGAGAGCAGACTGAC, R: CGCTGCTGCAAGAGACT)
Patched1 (F: AAGCCGACTACATGCCAGAG, R: AAGGGAACTGAGCGT
ACTCG)
Fgf8 (F: AGGTCTCTACATCTGCATGAAC, R: TGTTCTCCAGCACGAT
CTCT)
Erm (F: TGCCCACTTCATCGCCTGGAC, R: TAGCGGAGAGAGCGGC
TCAG)
Staining and Histology
All mRNA in situ hybridization, immunohistochemistry, b-gal activity, and his-
tological staining were performed according to standard protocols. Mouse
Figure 6. Ofd-1 Mutants Also Show Expanded Maxillary Compart-
ments and Cranial FGF8 Expression Domains
(A–D) Lateral views of E9.5 embryos showing cranial Fgf8 mRNA expression
domains. The 21 and 23 somite ofd-1 mutants have enlarged maxillae
compared to stage-matched control embryos, indicated by yellow brackets in
(B) and (D) compared to (A) and (C), respectively. Maxillary Fgf8 expression is
expanded in mutants compared to controls [brackets in (B) and (D) compared
to (A) and (C), as well as expression in the frontonasal process, indicated
by arrowheads].
(E–G) OFD-1 and Apert syndrome patients exhibit high arched palate. In (E), a
ventral view of a normal palate shows a hard palate with shallow, anterior
bilateral rugae and smooth posterior palate (after photo by Millicent Odunze:
http://plasticsurgery.about.com/od/Cleft-Lip-And-Palate/ss/
What-Is-A-Cleft-Palate_3.htm). In (F), a ventral view is shown of the palate from
OFD 1 (OFD-1) patient (after Tagliani et al., 2010; Figure 2F). (G) shows a
ventral view of palate from the Apert syndrome patient (after Rynearson, 2000).
Both (F) ciliopathic and (G) FGF-related high arched palates are narrow with a
deep medial cleft extending from the anterior hard palate. Rugal-like swellings
are more numerous and are extant with the medial cleft. Soft tissue swellings
and dental crowding are observed in both groups.
(H–I0) Loss of Fuz causes coronal craniosynostosis. E17.5 heads stained with
Alizarin red. (H) and (I) show dorsolateral views. (H0) and (I0) show dorsal views.
Alizarin red negative coronal suture (open arrowheads) separates frontal (F)
and parietal (P) bones in wild-type embryos. Coronal suture is absent in mutant
embryos (closed arrowheads).
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and Xenopus embryos were collected in cold PBS and fixed overnight in 4%
paraformaldehyde or MEMFA, respectively. mRNA in situ hybridization was
performed as previously described (Sive et al., 2000; Wilkinson et al., 1989).
The following mRNA probes were used: mouse Fgf8 (Mahmood et al., 1995),
mouse erm (Hippenmeyer et al., 2002), mouse Pea3 (Livet et al., 2002),
X. laevis Fgf8 (Monsoro-Burq et al., 2003), and X. laevis twist (Hopwood
et al., 1989). Primary antibodies used for immunohistochemistry: anti-rabbit
phospho-histone H3 (PH3) (BDH, 1:200) or anti-rabbit b-catenin (Sigma,
1:200). Sections were coverslipped with ProLong Gold antifade reagent with
DAPI (Invitrogen, P36931).
Confocal Microscopy and Image Analysis
To analyze NCmigration, whole-mount E9.0 embryos were cleared using 70%
glycerol/PBS andmounted on slides. Sagittal confocal z-stacks were obtained
using a Leica TCS SP5 DM16000. Image sequences were reconstructed using
Imaris image analysis software. Thickness of NC streams were determined by
measuring the depth of GFP positive NC cells at three points anterior to the
trigeminal ganglion, posterior to the maxillary compartment (outlined in
Figure 3).
mCT
Specimens were scanned using a GE Explore Locus SP mCT scanner. The
specimens were immersed in 20% (w/v) Pluronic F-127 (Sigma) at 4C and
warmed to room temperature for immobilization. Specimens were scanned
to produce 8 mm voxel size volumes, using an X-ray tube voltage of 80 kVp
and a tube current of 80 mA. An aluminum filter (0.05 mm) was used to adjust
the energy distribution of the X-ray source. The specimens were characterized
further by making three-dimensional isosurfaces, generated and measured
using Microview software (GE).
Flow Cytometry of Embryo Heads
Cell purification from embryonic tissues was performed as previously
described (Schulz et al., 2012). Heads from Wnt1-cre; R26mT/mG embryos,
as depicted in Figure 2E, were digested and passed through a 100 mm cell
strainer. Flow cytometry was performed using a BD Biosciences FACSAria II
cell sorter. Live cells were identified using side scatter and forward
scatter (FSC-A), followed by doublet exclusion using forward scatter
width against FSC-A. Populations were identified using endogenous exp-
ression of GFP and Tomato. All data were analyzed using FlowJo 9.53
(Celeza GmbH).
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Figure 7. Proposed Model for Palatal Defects in Fuz Mutants
(A and B) Schematics depict E8.5 embryos. In Hedgehog signaling, anterograde transport delivers Gli3L (Gli3-activator) to the distal CLAMP-positive ciliary tip
(red). Gli3-L is processed into Gli3-S (Gli3 repressor) which undergoes retrograde transport, repressing transcription of targets such as FGF8. Anterior NC (dark
green) arises from the posterior mesencephalon and anterior hindbrain (purple), and is normally limited by a balance of Hh and FGF signals. NC thenmigrates into
BA1, comprising maxillary and mandibular compartments (Mx and Md, respectively). When Fuz function is lost, ciliary transport and the distal compartment are
severely disrupted leading to disruption of Gli processing and an expansion in cranial NC numbers, specifically maxillary NC.
(C–F) In (C) and (D), schematics depict coronal sections of E9.5 embryos. In coronal sections, the maxilla forms as two bilateral prominences and Fgf8 is
expressed in lateral maxillary epithelia, indicated by purple in (C) through (F). In mutants, themaxillary compartment is enlarged and epithelial Fgf8 is expanded. In
(E) and (F), schematics depict coronal sections of E10.5 embryos. Palatal condensations (red) aremedial to FGF8 expression domains. In wild-type animals, these
flank midline mesenchyme but remain separated. In Fuz mutants, expansion of FGF8 causes a medial shift of the palatal condensations. Subsequently, the
normal bilateral palatal primordia join at the midline.
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